SHARE
COPY LINK

FEATURE

Several cases of new Covid-19 variant detected in Norway

A new variant of Covid-19 has been detected in Norway, the country’s health authority has said. The variant has similarities to existing, more infectious variants.

Several cases of new Covid-19 variant detected in Norway
Illustration photo: AFP

The new variant, B1525, has similarities to both the B117 variant, first detected in the United Kingdom; and variant B1351, first detected in South Africa, Norwegian national broadcaster NRK reports.

Around ten cases of the B1525 variant have been found in Norway in the last day, according to the report. The variant has also been found in Denmark, the UK and the United States.

“We don’t yet know yet whether it is more infectious, but it could be. There are changes to the part of the virus which may affect infectiousness,” Line Vold, head of department at the Norwegian Institute of Public Health (NIPH), told NRK.

Norway, like Denmark, the UK and Iceland, analyses a large proportion of positive Covid-19 swabs to test for new variants.

That could be a reason for the apparent emergence of the new variant in the Nordic country, Vold said.

“Many countries are not as good at doing the demanding analyses which tell us which type of virus is circulating,” she told NRK.

NIPH is monitoring the B117 and B1351 variants in particular.

Both have been shown to be significantly more infectious than previous forms of Covid-19. The former now comprises around one in seven new infections in Oslo, with up to 700 cases so far identified.

A total of 42 cases of the B1351 variant have also been detected.

Vold said the new B1525 variant will be monitored as is practice with potentially infectious mutations. It was too early to say whether the cases were brought in to Norway from abroad or are community transmissions, NRK writes.

The emergence of new variants in general is natural, Vold said.

“We also see changes in other mutations circulating in (Norway). New variants are spreading in the world and it’s a natural evolution of the virus that it keeps changing,” she said.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS